Rain Therapeutics Price on February 17, 2023

RAINDelisted Stock  USD 1.41  0.01  0.70%   
If you're considering investing in Rain Stock, it is important to understand the factors that can impact its price. As of today, the current price of Rain Therapeutics stands at 1.41, as last reported on the 29th of November, with the highest price reaching 1.42 and the lowest price hitting 1.36 during the day. We have found twenty-three technical indicators for Rain Therapeutics, which you can use to evaluate the volatility of the company. Please check Rain Therapeutics' Risk Adjusted Performance of (0.03), variance of 132.09, and Coefficient Of Variation of (1,877) to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Rain Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
RAIN
Based on monthly moving average Rain Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Rain Therapeutics by adding Rain Therapeutics to a well-diversified portfolio.

Related Headline

Elevation Oncology Headline on 17th of February 2023

Filed transaction by Elevation Oncology Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Rain Therapeutics Valuation on February 17, 2023

It is possible to determine the worth of Rain Therapeutics on a given historical date. On February 17, 2023 Rain was worth 9.36 at the beginning of the trading date compared to the closed value of 9.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Rain Therapeutics stock. Still, in general, we apply an absolute valuation method to find Rain Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rain Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Rain Therapeutics' related companies.
 Open High Low Close Volume
  9.05    9.73    8.90    9.52    274,436  
02/17/2023
  9.36    9.66    9.00    9.50    299,605  
  9.66    9.89    8.66    8.66    360,087  
Backtest Rain Therapeutics  |  Rain Therapeutics History  |  Rain Therapeutics Valuation   PreviousNext  
Open Value
9.36
9.5
Closing Value
9.36
Upside

Rain Therapeutics Trading Date Momentum on February 17, 2023

On February 21 2023 Rain Therapeutics was traded for  8.66  at the closing time. The top price for the day was 9.89  and the lowest listed price was  8.66 . The trading volume for the day was 360.1 K. The trading history from February 21, 2023 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 8.84% . The trading delta at closing time against the current closing price is 8.32% .

Rain Therapeutics Fundamentals Correlations and Trends

By evaluating Rain Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Rain Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Rain financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Rain Therapeutics Stock history

Rain Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Rain is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Rain Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Rain Therapeutics stock prices may prove useful in developing a viable investing in Rain Therapeutics
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California. Rain Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 44 people.

Rain Therapeutics Stock Technical Analysis

Rain Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Rain Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Rain Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Rain Therapeutics Period Price Range

Low
November 29, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Rain Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Rain Therapeutics November 29, 2024 Market Strength

Market strength indicators help investors to evaluate how Rain Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rain Therapeutics shares will generate the highest return on investment. By undertsting and applying Rain Therapeutics stock market strength indicators, traders can identify Rain Therapeutics entry and exit signals to maximize returns

Rain Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Rain Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Rain Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Rain to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Consideration for investing in Rain Stock

If you are still planning to invest in Rain Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rain Therapeutics' history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation